Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -1.53% | -1.43% | +71.67% | +129.70% | 57.72B | |
| -2.45% | -7.32% | +65.23% | +83.15% | 52.65B | |
| +3.27% | +9.29% | +20.20% | +486.76% | 24.46B | |
| -0.81% | +0.52% | -15.01% | -12.47% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.24% | +5.40% | +44.65% | -26.41% | 17.8B | |
| +2.34% | +14.18% | +220.96% | +380.99% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| -1.70% | +3.12% | +27.06% | +190.57% | 14.35B | |
| Average | -4.13% | +5.20% | +57.02% | +153.33% | 26.96B | |
| Weighted average by Cap. | -1.26% | +2.71% | +58.01% | +141.66% |
Employees
4
Choose MarketScreener 
